Determination of Bone Volume Changes of the Cranial Bone-augmented Jaw: A Feasibility Study
NCT ID: NCT02810184
Last Updated: 2022-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
16 participants
OBSERVATIONAL
2016-06-30
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Registry of Immediate/Delayed Loading of Implants in the Cranial Bone-grafted Severely Atrophic Jaw
NCT02664298
Accuracy and Outcome of Computer-assisted Surgery for Bony Micro-vascular Reconstruction in the Head and Neck Region
NCT03054012
Comparison of Calcium Phosphate Cement With Patient-specific Implants for Cranial Reconstruction
NCT03841643
Intra-operative (IO) Navigation and IO-CBCT for 3D Orbital Reconstruction
NCT03057405
Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction
NCT02661139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Bone augmentation provides a solution for patients with a severely atrophic jaw to achieve immediate fixed prosthetic rehabilitation. Studies reporting total bone volume changes are lacking.
Objectives
The investigators aim to determine the level of total bone volume remodeling at 6, 24 and 36 months post-surgery in patients who underwent immediate prosthetic rehabilitation through a cranial bone-grafted maxilla in combination with immediate provisional implant (IPI) placement.
Study design
A prospective, longitudinal study.
All patients will be recruited at time of pre-surgical consultation.
During the surgical procedure, autogenous cranial graft reconstruction of the jaw is carried out under general anaesthesia.
Cone-beam CT (CBCT) scans (NewTom VGi evo, QR Verona, Italy) will be taken pre-operatively, and at different time-points post-operatively to evaluate the remodeling process of the bone after the grafting procedure with implant placements and assess the total bone volume changes up to 3 years post-surgically.
CBCT scans will be send to the oral maxillofacial surgery (OMFS) Research Group within the Department of Imaging and Pathology (IMPATH), Catholic University Leuven (liaised with the clinical department of Oral and Maxillofacial Surgery; University Hospital Leuven) for analysis of the total bone volume.
Data related to patient demographics, clinical diagnosis, the surgical procedure, IPI stability, and total bone volume at different time-points will be registered by a clinical research coordinator.
Conclusion
This prospective trial could add important knowledge to the field, and provide indications to improve future clinical pre-prosthetic management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBCT arm
all participating patients receive an additional CBCT scan at 24 and 36 months, for analysis of evolution of bone volume
cone-beam computed tomography (CBCT)
additional CBCT scan at 24 and 36 months, for analysis of evolution of bone volume
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cone-beam computed tomography (CBCT)
additional CBCT scan at 24 and 36 months, for analysis of evolution of bone volume
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with moderate to extreme bone atrophy of the jaw (class IV to VI according to Cawood and Howell (Cawood \& Howell, 1988), caused by terminal periodontitis or edentulism
* Patients requiring bone augmentation procedures through cranial bone-grafting for jaw reconstruction
* Patients requesting immediate prosthetic rehabilitation, through the placement of an immediate provisional implant (IPI)-supported fixed bridge (immediate loading)
Exclusion Criteria
* Patients with severe uncontrollable diabetes
* Patients with a smoking habit of \>10 cigarettes/day
* Patients with severe sinusitis problems
* Patients with insufficient cranial bone thickness
* Patients with bone remodeling or systemic diseases, or undergoing systematically administered treatments affecting bone remodeling
* Patients in whom postoperative complications (e.g. sinusitis, infections) occurred, will be excluded from the analysis, since these could be responsible for short-term bone volume loss confounding long-term results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AZ Sint-Jan AV
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan Abeloos
Head of department, Division of Maxillofacial surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan Abeloos, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Head of Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Maxillofacial Surgery, Department of Surgery, AZ Sint-Jan Brugge-Oostende AV
Bruges, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B049201627591
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.